Close

Dr Fabio Girardi

Honorary Research Fellow

United Kingdom

Fabio is a practising medical oncologist and epidemiologist. 

After completing his medical training in Padova (Italy), Fabio worked for several years as a consultant, mostly in community hospitals. In 2015 Fabio moved to the UK to embark on an MPhil in Epidemiology at the University of Cambridge, and, in 2017, on a funded PhD with the Cancer Survival Group at the London School of Hygiene and Tropical Medicine. Here he contributed to the CONCORD programme for the global surveillance of population-based cancer survival. During his PhD, Fabio had also the opportunity to serve as a commissioner for the Lancet Oncology Commission on Sustainable Care for Children with Cancer.

Fabio was awarded his PhD in April 2021 with the thesis, “Global surveillance of survival from intrinsic brain tumours diagnosed during 2000-2014: trends by age and histology”, and went on to collaborate with the Cancer Survival Group as an Honorary Clinical Assistant Professor in Cancer Epidemiology.

In 2020 Fabio relocated to his home country to take on a post as senior consultant medical oncologist at the Istituto Oncologico Veneto in Padova, a cancer referral centre in the northeast of Italy, where he specialises in breast cancer management. Fabio’s research interests include trends in population-based cancer survival and research synthesis.

Affiliations

Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Selected Publications

Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis
Pasello, G; Pavan, A; De Nuzzo, M; Frega, S; Ferro, A; Dal Maso, A; Bonanno, L; Guarneri, V; GIRARDI, F;
2024
Frontiers in Oncology
The Impact of COVID-19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center in Italy.
GIRARDI, F; Marini, S; Porra, F; Carpentieri, S; Marchet, A; Saibene, T; Lo Mele, M; Giarratano, T; Giorgi, CA; Mioranza, E; Falci, C; Faggioni, G; Caumo, F; Griguolo, G; Dieci, MV; Guarneri, V;
2023
The oncologist
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics.
Amato, O; Guarneri, V; GIRARDI, F;
2023
Current opinion in oncology
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.
Bonanno, L; Lorenzi, M; Massa, D; De Nuzzo, M; Angerilli, V; Zingone, F; Barberio, B; Russi, A; GIRARDI, F; Ferro, A; Dal Maso, A; Frega, S; Pasello, G; Dei Tos, AP; Coppola, M; Coppola, M; Fassan, M; Savarino, EV; Guarneri, V;
2023
The oncologist
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer.
Miglietta, F; Ragazzi, M; Fernandes, B; Griguolo, G; Massa, D; GIRARDI, F; Bottosso, M; Bisagni, A; Zarrilli, G; Porra, F; Iannaccone, D; Dore, L; Gaudio, M; Santandrea, G; Fassan, M; Lo Mele, M; De Sanctis, R; Zambelli, A; Bisagni, G; Guarneri, V; Dieci, MV;
2023
Clinical cancer research
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases.
Bottosso, M; Griguolo, G; Sinoquet, L; Guarascio, MC; Aldegheri, V; Miglietta, F; Vernaci, G; Barbieri, C; GIRARDI, F; Jacot, W; Guarneri, V; Darlix, A; Dieci, MV;
2023
British journal of cancer
Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3).
GIRARDI, F; Matz, M; Stiller, C; You, H; Marcos Gragera, R; Valkov, MY; Bulliard, J-L; De, P; Morrison, D; Wanner, M; O'Brian, DK; Saint-Jacques, N; COLEMAN, MP; ALLEMANI, C; CONCORD Working Group,;
2022
Neuro-oncology
Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3).
GIRARDI, F; DI CARLO, V; Stiller, C; Gatta, G; Woods, RR; Visser, O; Lacour, B; Tucker, TC; COLEMAN, MP; ALLEMANI, C; CONCORD Working Group,;
2022
Neuro-oncology
See more information